These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus. Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152 [TBL] [Abstract][Full Text] [Related]
25. Placental and fetal alterations due to Venezuelan equine encephalitis virus in rats. García-Tamayo J; Esparza J; Martínez AJ Infect Immun; 1981 May; 32(2):813-21. PubMed ID: 7251148 [TBL] [Abstract][Full Text] [Related]
26. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Charles PC; Walters E; Margolis F; Johnston RE Virology; 1995 Apr; 208(2):662-71. PubMed ID: 7747437 [TBL] [Abstract][Full Text] [Related]
28. [The course of airborne infection in rabbits infected with the Venezuelan encephalomyelitis virus]. Sergeev AN; Ryzhikov AB; Bulychev LE; Stepkina EO; Tkacheva NV Vopr Virusol; 1991; 36(6):492-5. PubMed ID: 1785185 [TBL] [Abstract][Full Text] [Related]
29. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus]. Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922 [TBL] [Abstract][Full Text] [Related]
30. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Watts DM; Lavera V; Callahan J; Rossi C; Oberste MS; Roehrig JT; Cropp CB; Karabatsos N; Smith JF; Gubler DJ; Wooster MT; Nelson WM; Hayes CG Am J Trop Med Hyg; 1997 Jun; 56(6):661-7. PubMed ID: 9230800 [TBL] [Abstract][Full Text] [Related]
31. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses. Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002 [TBL] [Abstract][Full Text] [Related]
32. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection. Bowen GS; Rayfield EJ; Monath TP; Kemp GE J Med Virol; 1980; 6(3):227-34. PubMed ID: 7014785 [TBL] [Abstract][Full Text] [Related]
33. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396 [TBL] [Abstract][Full Text] [Related]
34. Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus. Valero N; Nery A; Bonilla E; Espina LM; Chacin-Bonilla L; Añez F; Maldonado M; Meleán E Neurochem Res; 2009 Feb; 34(2):268-73. PubMed ID: 18594966 [TBL] [Abstract][Full Text] [Related]